Why the study?
Pulmonary arterial hypertension is associated with impaired quality of life and survival, yet there are limited data regarding palliative care in this population.
Does palliative care improve outcomes in patients with pulmonary arterial hypertension?
Does palliative care improve outcomes in patients with pulmonary arterial hypertension?
There is a strong rationale for involving palliative care specialists in the longitudinal management of pulmonary arterial hypertension despite limited current evidence.
PC may aid symptom relief in PAH; leaves open optimal timing and outcomes pending higher-level trials.
Background: Pulmonary arterial hypertension (PAH) is a chronic and progressive disease associated with impaired health-related quality of life and survival. Palliative care (PC) is patient-and family-centered care provided by an interdisciplinary team with an overarching goal of alleviating suffering and improving quality of life for patients with advanced illness. PC in other chronic diseases is associated with improved quality of life, symptom management, illness understanding, and reduced caregiver burden, but there is limited data regarding PC in PAH. Despite limited evidence, there is strong rationale for involving PC specialists in the longitudinal management of PAH.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: